Yuksel Kemal, Celik Ugur, Alagoz Cengiz, Dundar Huseyin, Celik Burcu, Yazıcı Ahmet Taylan
Department of Ophthalmology, Beyoglu Eye Training and Research Hospital, Istanbul, Turkey.
Department of Ophthalmology, Gaziosmanpaşa Taksim Training and Research Hospital, Istanbul, Turkey.
BMC Ophthalmol. 2015 Jul 16;15:75. doi: 10.1186/s12886-015-0067-2.
To evaluate the morpho-functional outcomes and safety of transconjuctival 23-gauge pars plana vitrectomy(PPV) for removal of intraocular foreign bodies (IOFBs).
A retrospective study of 36 consecutive cases (mean age; 34,2 ± 10,9 years (between 15 and 60), 27 M,9 F) of 23-G PPV for the removal of IOFBs during the period of April 2009 and December 2011 and followed 9,4 ± 6,4(2-27) months were conducted. Visual outcomes, slit lamp biomicroscopy, intraocular pressure (IOP), and posterior segment visualization by indirect ophthalmoscopy, A-B mode ultrasonography, and computed orbital tomography were performed for all cases. Main outcomes including anatomic and visual outcomes, and both intraoperative and postoperative complications were recorded.
Of the 36 cases available for the study, the IOFBs (size range, 3 to 12 mm) could be removed in all eyes. Mean preoperative LogMAR BCVA was 1.44 ± 138 (range, 1.00 to 0.00) and mean postoperative LogMAR BCVA at final visit was 0,78 ± 0,98 (range, 1.00 to 0.00). (P = 0,007) Anatomic success was obtained in 97.2 % of eyes. 16 patients needed primary wound repair due to the leakage in insertion sites before the PPV, however remaining 20 cases were not. Fibrin reaction was seen in 8 (22.2 %) patients in early postoperative period, intraocular pressure elevation was detected in 12 (33.3 %) patients in which the silicone oil was used as an intravitreal tamponade, one patient with silicone oil tamponade developed band keratopathy and phthisis bulbi.
23-Gauge PPV is a feasible, effective approach in the surgical management of the patients with posterior segment intraocular foreign bodies.
评估经结膜23G玻璃体切除术（PPV）取出眼内异物（IOFBs）的形态功能结局及安全性。
对2009年4月至2011年12月期间连续36例（平均年龄34.2±10.9岁（15至60岁），男27例，女9例）因取出IOFBs行23G PPV的患者进行回顾性研究，并随访9.4±6.4（2至27）个月。对所有病例进行视力结局、裂隙灯生物显微镜检查、眼压（IOP）以及通过间接检眼镜、A - B型超声检查和眼眶计算机断层扫描进行的后段可视化检查。记录主要结局，包括解剖和视力结局以及术中及术后并发症。
在可供研究的36例病例中，所有患眼的IOFBs（大小范围为3至12mm）均成功取出。术前平均LogMAR BCVA为1.44±1.38（范围为1.00至0.00），末次随访时术后平均LogMAR BCVA为0.78±0.98（范围为1.00至0.00）。（P = 0.007）97.2%的患眼获得了解剖学成功。16例患者因PPV前插入部位渗漏需要进行一期伤口修复，然而其余20例则无需修复。8例（22.2%）患者在术后早期出现纤维蛋白反应，12例（33.3%）使用硅油作为玻璃体腔填塞物的患者检测到眼压升高，1例使用硅油填塞的患者发生了带状角膜病变和眼球痨。
23G PPV是手术治疗后段眼内异物患者的一种可行、有效的方法。
